Baker Daniel G. 4
4 · Cue Biopharma, Inc. · Filed Nov 29, 2024
Insider Transaction Report
Form 4
Baker Daniel G.
CHIEF DEVELOPMENT OFFICER
Transactions
- Award
Stock Option (right to buy)
2024-11-25+200,000→ 200,000 totalExercise: $1.06Exp: 2034-11-24→ Common Stock (200,000 underlying)
Footnotes (2)
- [F1]Represents an inducement stock option granted on November 25, 2024.
- [F2]This stock option will become exercisable over two years in equal, semi-annual installments beginning on May 25, 2025.